Xizang Weixinkang Pharmaceutical Co., Ltd. Class ASSE: 603676

Announcement on Passing the Consistency Evaluation of Generic Drug Quality and Efficacy for Subsidiary Drugs

· Issued by Xizang Weixinkang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Passing the Consistency Evaluation of Generic Drug Quality and Efficacy for Subsidiary Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment